Blood vials. Photo: Getty Images/Science Photo Library As scientists around the world have raced to understand COVID-19, the general public has been inundated with a flurry of early studies and ensuing recommendations, some of which have been contradictory, leaving us with “coronavirus whiplash.” A recent source of confusion has been the relationship between the coronavirus…
In the ongoing mission to understand why some people are more impacted by COVID-19 than others, in the past six months researchers have learned that blood type plays a major role. Several studies have found links between specific blood types and not only the likelihood of contracting the virus, but also risk of death. Now,…
This 2020 electron microscope made available by the U.S. Centers for Disease Control and Prevention image shows the spherical coronavirus particles from the first U.S. case of COVID-19. (C.S. Goldsmith, A. Tamin/CDC via AP)OAN Newsroom UPDATED 1:18 PM PT —Saturday, July 11, 2020A new study has discovered more about the effects of COVID-19 on the…
The roulette wheel that decides who lives and dies from the coronavirus is weighted by the type of blood coursing through the veins of victims, gifting some with innate resistance and dooming others to misery and torment. Infectious disease specialists say the worldwide pandemic is especially cruel to people with type A blood, which apparently…
If there’s one thing we want to know about COVID-19, it’s probably this: What’s my risk of getting it?Researchers have identified certain things that make some people more vulnerable than others. Men are at greater risk than women. Older people are at greater risk than younger people. Those with chronic health problems like Type 2…
6 min read Long gone are the days when cheating was as easy to spot as a lipstick smudge on a shirt collar. In 2026, infidelity often takes the smaller, yet nonetheless shitty, form of “microcheating.” It could be a borderline flirty text to a colleague or check-ins with an old “friend” that start out
You don't have permission to access "http://www.medpagetoday.com/transplantation/hearttransplantation/119412" on this server. Reference #18.8a1c1602.1768366940.7e14c81d https://errors.edgesuite.net/18.8a1c1602.1768366940.7e14c81d
4 min read A new study found people lost an average of 32.4 pounds while on semaglutide and tirzepatide. People who discontinue GLP-1 drugs regained nearly 22 pounds within a year. They returned to their starting weight in less than 2 years. Doctors say there's three common mistakes people make that is likely contributing to